Summary Slide.png (75.04 kB)

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination With Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study

media

posted on 2020-05-14, 09:46 authored by Lu Wang, Yujing Di, Tingting Guo, Jeffrey E. Ming, Fangyuan Kong, Huiqiu Yin, Linlin Zhang, Fang Xie, Na Yang, Chuan Ping, Yi Li, Jie Hou

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Acetylsalicylic acid Bioequivalence Clopidogrel Co-Plavix Fixed dose combination RSABE

Licence

CC BY-NC 4.0

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination With Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study

History

Usage metrics

Categories

Keywords

Licence

Exports